Morbidity Completed Phase 3 Trials for Bacillus calmette-guerin substrain danish 1331 live antigen (DB12386)

Back to Morbidity

Also known as: Morbidities

IndicationStatusPhase
DBCOND0032134 (Morbidity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04542330Using BCG to Protect Senior Citizens During the COVID-19 PandemicPrevention